Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortcomings: poorly prepared experiments and results that don’t carry any clout. Instead of merely leveling criticism, however, Empa is also developing new standards for such experiments within an international network.
NaturalNano, Inc. announced today the formation of its ViralProtec Division to service the growing demand for Personal Protective Equipment (PPE). The recent public concern and publicity surrounding the increased risk to caregivers and other responders created by the Ebola virus as well as other public health concerns has raised awareness of the need for additional precautionary steps for those dealing with these issues.
A research team consisting of Osami Sakata, the director of the Synchrotron X-ray Station at SPring-8, Research Network and Facility Services Division, NIMS; Professor Hiroshi Kitagawa, Graduate School of Science, Kyoto University; and Professor Michihisa Koyama, Inamori Frontier Research Center, Kyushu University, made the first observation of the electronic structure in silver-rhodium (Ag-Rh) alloy nanoparticles to investigate why the alloy possesses a hydrogen absorbing/storage property like palladium (Pd) does, given that bulk Ag and Rh do not form an alloy, and that neither element alone is a hydrogen absorbing/storage metal.
Furthering Governor Andrew M. Cuomo’s entrepreneurial vision for education in New York State, the Colleges of Nanoscale Science and Engineering (CNSE) at SUNY Polytechnic Institute (SUNY Poly) today announced that Eonix, a clean energy startup born at SUNY Poly and led by CNSE graduate students, has been awarded a $250,000 grant from the New York State Energy Research and Development Authority (NYSERDA).
Research and Markets has announced the addition of the "The Global Market For Carbon Nanotubes, Graphene And Other 2-D Nanomaterials " report to their offering.
In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led by Jean-François Masson and Joelle Pelletier of the university's Department of Chemistry.
A University of Houston researcher is trying a novel approach to create high efficiency, low cost solar cells in an effort to bring the cost down to that of traditional electricity sources.
Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer.
Supporting Governor Andrew M. Cuomo’s vision which has transformed New York into a globally recognized innovation hub for high-tech industry, the Colleges of Nanoscale Science and Engineering (CNSE) at SUNY Polytechnic Institute (SUNY Poly) today announced plans for the seventh annual celebration of NANOvember.
Research and Markets has announced the addition of the "The Global Market for Anti-Microbial Nanocoatings" report to their offering.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.